These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 17685741)
1. Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey. Suvisaari JM; Saarni SI; Perälä J; Suvisaari JV; Härkänen T; Lönnqvist J; Reunanen A J Clin Psychiatry; 2007 Jul; 68(7):1045-55. PubMed ID: 17685741 [TBL] [Abstract][Full Text] [Related]
2. Type 2 diabetes among persons with schizophrenia and other psychotic disorders in a general population survey. Suvisaari J; Perälä J; Saarni SI; Härkänen T; Pirkola S; Joukamaa M; Koskinen S; Lönnqvist J; Reunanen A Eur Arch Psychiatry Clin Neurosci; 2008 Apr; 258(3):129-36. PubMed ID: 17990051 [TBL] [Abstract][Full Text] [Related]
9. Mortality and its determinants in people with psychotic disorder. Suvisaari J; Partti K; Perälä J; Viertiö S; Saarni SE; Lönnqvist J; Saarni SI; Härkänen T Psychosom Med; 2013 Jan; 75(1):60-7. PubMed ID: 23257931 [TBL] [Abstract][Full Text] [Related]
10. Associations between clinical and psychosocial factors and metabolic and cardiovascular risk factors in overweight patients with schizophrenia spectrum disorders - Baseline and two-years findings from the CHANGE trial. Storch Jakobsen A; Speyer H; Nørgaard HCB; Hjorthøj C; Krogh J; Mors O; Nordentoft M Schizophr Res; 2018 Sep; 199():96-102. PubMed ID: 29501386 [TBL] [Abstract][Full Text] [Related]
11. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Perälä J; Suvisaari J; Saarni SI; Kuoppasalmi K; Isometsä E; Pirkola S; Partonen T; Tuulio-Henriksson A; Hintikka J; Kieseppä T; Härkänen T; Koskinen S; Lönnqvist J Arch Gen Psychiatry; 2007 Jan; 64(1):19-28. PubMed ID: 17199051 [TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome in antipsychotic naive African patients with severe mental illness in usual care. Saloojee S; Burns JK; Motala AA Early Interv Psychiatry; 2018 Dec; 12(6):1137-1143. PubMed ID: 28402033 [TBL] [Abstract][Full Text] [Related]
13. Lifetime Prevalence and Correlates of Schizophrenia-Spectrum, Affective, and Other Non-affective Psychotic Disorders in the Chinese Adult Population. Chang WC; Wong CSM; Chen EYH; Lam LCW; Chan WC; Ng RMK; Hung SF; Cheung EFC; Sham PC; Chiu HFK; Lam M; Lee EHM; Chiang TP; Chan LK; Lau GKW; Lee ATC; Leung GTY; Leung JSY; Lau JTF; van Os J; Lewis G; Bebbington P Schizophr Bull; 2017 Oct; 43(6):1280-1290. PubMed ID: 28586480 [TBL] [Abstract][Full Text] [Related]
14. A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 Birth Cohort study. Saari KM; Lindeman SM; Viilo KM; Isohanni MK; Järvelin MR; Laurén LH; Savolainen MJ; Koponen HJ J Clin Psychiatry; 2005 May; 66(5):559-63. PubMed ID: 15889940 [TBL] [Abstract][Full Text] [Related]
15. Persistent Low Rates of Treatment of Metabolic Risk Factors in People With Psychotic Disorders: A PHAMOUS Study. Bruins J; Pijnenborg GHM; van den Heuvel ER; Visser E; Corpeleijn E; Bartels-Velthuis AA; Bruggeman R; Jörg F J Clin Psychiatry; 2017; 78(8):1117-1125. PubMed ID: 28406264 [TBL] [Abstract][Full Text] [Related]
16. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey. Kendler KS; Gallagher TJ; Abelson JM; Kessler RC Arch Gen Psychiatry; 1996 Nov; 53(11):1022-31. PubMed ID: 8911225 [TBL] [Abstract][Full Text] [Related]
17. Hyperlipidemia in persons using antipsychotic medication: a general population-based birth cohort study. Saari K; Koponen H; Laitinen J; Jokelainen J; Lauren L; Isohanni M; Lindeman S J Clin Psychiatry; 2004 Apr; 65(4):547-50. PubMed ID: 15119919 [TBL] [Abstract][Full Text] [Related]
18. Hearing loss in persons with psychotic disorder--findings from a population-based survey. Viertiö S; Perälä J; Saarni S; Koskinen S; Suvisaari J Schizophr Res; 2014 Nov; 159(2-3):309-11. PubMed ID: 25217365 [TBL] [Abstract][Full Text] [Related]
19. Coronary heart disease and cardiac conduction abnormalities in persons with psychotic disorders in a general population. Suvisaari J; Perälä J; Saarni SI; Kattainen A; Lönnqvist J; Reunanen A Psychiatry Res; 2010 Jan; 175(1-2):126-32. PubMed ID: 19926142 [TBL] [Abstract][Full Text] [Related]
20. Comparison of metabolic syndrome incidence among schizophrenia patients treated with aripiprazole versus olanzapine or placebo. L'Italien GJ; Casey DE; Kan HJ; Carson WH; Marcus RN J Clin Psychiatry; 2007 Oct; 68(10):1510-6. PubMed ID: 17960964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]